BioSpace News Archive

Carle Health today joined Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, in announcing a five year, multi-million dollar strategic partnership

Impulse Dynamics, a medical device company dedicated to improving the lives of heart failure patients, today announced the publication of the FIX-HF-5C2 study in Circulation: Heart Failure.

Iodine, known for its potent antibacterial effects, has been in use in a variety of formulations, particularly to disinfect skin and mucosa

Cancer informatics and digital pathology solution provider Inspirata announced earlier this week its free remote pathology initiative, available to healthcare institutions looking to provide flexibility to their staff during COVID-19

Lumiata uses artificial intelligence to address the cost and risk of healthcare for customers.

Advanced Sterilization Products (ASP), a Fortive (NYSE:FTV) company and global leader in infection prevention, has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for the use of STERRAD® Systems to decontaminate compatible N95 respirators

Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate the endocannabinoid system and related biological signaling pathways, today reported financial and operating results for the second quarter of its fiscal year ended February 29, 2020. “We are pleased to report the progress achieved with our programs during the second quarter,” said Gregory D. Gorg

Marrone Bio Innovations Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, today announced that management will attend the SNN Planet MicroCap Showcase Virtual Investor Conference on Wednesday, April 22, 2020. Pam Marrone, CEO and Founder of Marrone Bio Innovations, Jim Boyd, Chief Financial Officer and Kevin Hammill, Chief Commercial Officer will host virtual one-on-one meetings througho

Leading Remote Trial Management and Risk-Based Monitoring Organization to Use eISF, eTMF, and LMS Solutions

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing potential new therapies for cancer, today announced the appointment of Cheryl L. Cohen to its board of directors.